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Superoxide dismutase, catalase, glutathione peroxidase and Chronic exposure to low levels of lead causes sustained
NADPH oxidase in lead-induced hypertension. arterial hypertension (HTN) that persists indefinitely
Background. Earlier studies from this laboratory have re- after the cessation of lead exposure in humans and exper-vealed the presence of oxidative stress and its role in the patho-
imental animals [1–8]. In a series of earlier studies [1–5],genesis of lead-induced hypertension (HTN). We have further
shown evidence of increased hydroxyl radical (·OH) and super- we have demonstrated that lead-induced HTN is associ-
oxide production in lead-treated rats and cultured endothelial ated with oxidative stress and increased production of
cells. This study was designed to determine whether oxidative reactive oxygen species (ROS). We have further shownstress in animals with lead-induced HTN is associated with
that the associated oxidative stress plays a major role indysregulation of the main antioxidant enzymes namely super-
the pathogenesis of HTN via avid inactivation/oxidationoxide dismutase (SOD), catalase (CAT) and glutathione perox-
idase (GPX) or increased superoxide producing enzyme nico- of nitric oxide (NO) by ROS [1, 4]. In fact, alleviation
tinamide adenine dinucleotide (phosphate) oxidase [NAD(P)H]. of oxidative stress by a variety of antioxidants resulted
Methods. Male Sprague-Dawley rats were randomly assigned
in marked amelioration of HTN and enhanced NO avail-to lead-exposed and control groups. Animals in the lead-ex-
ability in rats with lead-induced HTN [1, 3–5]. Avid inac-posed group were provided with drinking water containing 100
ppm lead acetate for 12 weeks. The control group was provided tivation of NO by ROS was invariably associated with
with regular drinking water. At the conclusion of the experi- a compensatory up-regulation of NO synthase (NOS)
ment, immunodetectable Cu Zn SOD, Mn SOD, CAT, GPX
isoforms that was largely reversed by antioxidant therapyand gp91 phox subunit of NAD(P)H oxidase were determined
in lead-treated animals [3, 5].by Western analysis in the kidney, brain and left ventricle of
control and lead-exposed rats. Subgroups of the study animals In a series of earlier studies, we found strong evidence
were treated with IV infusion (180 mol/kg/h) of the superox- for increased hydroxyl radical (·OH) in the lead-treated
ide trapping agent, tempol, and arterial pressure and urinary
rats and cultured endothelial cells. For instance, using anitric oxide (NO) metabolite (NOx) excretion were determined.
salicylate trapping technique, we found a marked increaseResults. Lead exposure for 12 weeks resulted in a marked
rise in systolic blood pressure, a significant reduction in urinary in ·OH radicals in various tissues of lead-treated rats and
NOx excretion, a significant increase in kidney and brain Cu, Zn in lead-treated cultured endothelial cells [9, 10]. The role
SOD, a significant increase in brain and insignificant increase in
of excess ·OH activity was further confirmed by the ob-kidney and heart gp91 phox. In contrast, Mn SOD, CAT and
servations that intravenous administration of the reputedGPX in the kidney, brain and left ventricle were unchanged.
Incubation with lead acetate did not alter SOD activity in vitro. ·OH scavenger, dimethythiourea (DMTU), resulted in
Infusion of tempol significantly lowered arterial pressure and a marked amelioration of HTN and increased urinary
raised urinary NOx excretion in the lead-exposed group (but excretion of NO metabolites (NOx) in rats with lead-had no effect in the control group) pointing to increased super-
induced HTN [10]. In contrast, intravenous administra-oxide production in the lead-exposed animals.
Conclusion. Animals with lead-induced hypertension exhib- tion of the native superoxide dismutase (SOD) alone or
ited oxidative stress which was associated with mild up-regula- together with catalase had no discernible effect on either
tion of superoxide-generating enzyme, NAD(P)H oxidase, with
blood pressure or urinary NOx excretion [11]. However,no evidence of quantitative SOD, CAT or GPX deficiencies.
as a peptide, native SOD is cell impermeable and as
such its lack of demonstrable action does not necessarily
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preclude increased cellular production of superoxidedismutase, tempol, nitric oxide, catalase, glutathione peroxidase,
NAD(P)H oxidase. anion. In an attempt to overcome this obstacle, we re-
cently used the cell-permeable SOD-mimetic agent, tem-Received for publication May 9, 2002
pol, in a study designed to explore the effect of leadand in revised form July 26, 2002
Accepted for publication August 12, 2002 exposure on SOD production in cultured human coro-
nary endothelial cells. The results revealed a marked 2003 by the International Society of Nephrology
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increase in lipid peroxidation product, malondialdehyde Determination of response to intravenous tempol
(MDA), denoting oxidative stress, coupled with a com- Under general anesthesia with thiobutabarbital (100
pensatory up-regulation of endothelial NO synthase mg/kg IP), the animals were instrumented as follows: A
(eNOS) expression in lead-treated endothelial cells. The tracheostomy was performed and a PE-240 catheter was
study further revealed normalization of MDA produc- placed in the trachea. A PE-90 catheter with a flared tip
tion and eNOS expression by superoxide-trapping drug was placed in the bladder for urine collection. In addi-
tempol in lead-exposed (but not control) cells [12]. The tion, PE-50 catheters were placed in the left carotid ar-
latter study provided strong evidence for increased su- tery and right jugular vein for direct blood pressure mea-
peroxide production in lead-treated endothelial cells. surement and intravenous infusions, respectively. After
These in vitro findings were subsequently confirmed in a 60-minute equilibration and a 30-minute saline infusion
our in vivo studies, which showed amelioration of HTN control period, animals were treated with continuous
and oxidative stress together with enhanced NO avail- IV infusion of tempol (180 mol/kg/h) for 30 minutes
ability and reversal of compensatory up-regulation of followed by a 30-minute recovery period during which
NOS isoforms by tempol administration in rats with lead- saline was infused. All infusions were carried out at a
induced HTN [5]. Since ·OH is produced from interac- rate of 2 mL/kg/h. Urine samples were collected during
tion of superoxide and hydrogen peroxide (H2O2) via each period and blood samples were obtained at the end
Fenton or Haber Weiss reactions, elevation of superox- of the control, tempol treatment and recovery periods.
ide production or its reduced dismutation can readily Arterial blood pressure was monitored directly via the
account for increased ·OH production in lead-treated carotid catheter that was connected to a Gould P-50
cultured cells and in intact animals observed in our ear- pressure transducer and recorded on a Dynograph
lier studies [9, 10]. The present study was undertaken to R511A recorder (Sensor Medics, Anaheim, CA, USA)
explore whether oxidative stress in lead-induced HTN is as previously described [13].
due to down regulation of the main antioxidant enzymes,
that is, superoxide dismutase (SOD) isoforms, catalase Measurements of SOD, catalase, glutathione
peroxidase and gp91 phox proteins(CAT) and glutathione peroxidase (GPX), or up-regula-
tion of the superoxide-generating enzyme, NAD(P)H Homogenates (25% wt/vol) of kidney, heart (left ven-
oxidase. tricle) and brain were prepared in 10 mmol/L HEPES
buffer, pH 7.4, containing 320 mmol/L sucrose, 1 mmol/L
ethylenediaminetetraacetic acid (EDTA), 1 mmol/L di-METHODS
thiothreitol (DTT), 10 g/mL leupeptin, 2 g/mL aproti-
Animals nin and 1 mmol/L phenylmethylsulfonyl fluoride (PMSF)
Male Sprague-Dawley rats with an average weight of at 0 to 4C with a polytron homogenizer. Homogenates
about 200 g were housed in a climate controlled light- were centrifuged at 9000  g for 10 minutes at 4C
regulated space with 12-hour light (500 Lux) and dark to remove nuclear fragments and tissue debris without
cycles. They were fed a regular rat chow ad libitum. The precipitating membrane fragments. A portion of the su-
animals were randomly assigned to lead-exposed and pernatant was used to determine the total protein con-
normal control groups. Animals in the lead-exposed centration by using a Bio-Rad kit (Hercules, CA, USA).
group were provided with a drinking water containing Total cellular protein (1 g for Cu, Zn SOD and 20
100 ppm lead acetate for 12 weeks. The control group g for Mn SOD, catalase, glutathione peroxidase and
was provided with regular drinking water. gp91 phox assays) was electrophoresed in 4 to 20% Tris-
At the conclusion of the observation period, tail arte- glycine sodium dodecyl sulfate (SDS) polyacrylamide
rial pressure was measured and animals were placed in gels (Novex, San Diego, CA, USA). Proteins were trans-
metabolic cages for a timed urine collection. The next ferred onto nitrocellulose membranes (Millipore Corp.,
day, the animals were anesthetized with an intraperito- Bedford, MA, USA), blocked in 5% dry milk in T-TBS
neal injection of sodium pentobarbital (50 mg/kg) and (0.02 mol/L Tris/0.15 mol/L NaCl, pH 7.5 containing
euthanized by exsanguination using cardiac puncture. 0.1% Tween 20) at room temperature for three hours,
Kidney, brain and heart were immediately harvested, washed three times with T-TBS and incubated with the
cleaned, snap-frozen in liquid nitrogen and stored at primary antibodies to the Cu, Zn SOD, Mn SOD (1:1000),
70C until being processed. The procedures were car- catalase (1:2000), glutathione peroxidase (1:250) and gp91
ried out between the hours of 9 a.m. to 11 a.m. phox (1:2000) for three hours at room temperature. All
An additional group of six lead-exposed and six con- of these antibodies were purchased from Calbiochem (San
trol rats were instrumented and used for the assessment Diego, CA, USA). After washing five times with T-TBS,
of changes in blood pressure and urinary NOx excretion the blots were incubated with secondary antibodies (anti-
in response to a single IV infusion of tempol (Sigma sheep for Cu, Zn SOD, Mn SOD and glutathione peroxi-
dase, 1:2000 and anti-rabbit for catalase 1:2000) conju-Chemical Co, St. Louis, MO, USA) as described below.
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Table 1. Systolic arterial blood pressure (BP), urinary NOx
excretion (UNOx), serum creatinine and body weight in the normal
control and lead-exposed groups
Serum Creatinine Body
BP U NO creatinine clearance weight
Groups mm Hg lmol/5 h mg/dL mL/min g
Control 1228 1.380.27 0.480.02 2.10.4 42427
Lead-Rxed 17911 0.760.13 0.490.04 2.30.2 42226
P values 0.01 0.01 NS NS NS
N  12 in each group; NS is not significant.
gated with horseradish peroxidase at room temperature
for two hours. After washing five times with T-TBS, the
membrane was developed using enhance chemilumines- Fig. 1. Systolic blood pressure measurements obtained via a carotid
catheter at baseline (), following a 30-minute IV infusion of tempolcent (ECL) reagent (Amersham Life Science Inc., Ar-
(180 mol/kg/h; ) and at the end of a 30-minute recovery period ()lington Heights, IL, USA) and subjected to autoluminog- in rats with lead-induced hypertension (lead) and control animals. N 
raphy for one to five minutes. The autoluminographs 6 animals in each group, Data are given as x SEM. *P 0.01 (ANOVA).
were scanned with a laser densitometer (Model PD 1211;
Molecular Dynamics, Sunnyvale, CA, USA) to determine
the relative optical densities of the bands. In all instances,
RESULTSthe membranes were stained with Ponceau stain, to ver-
General dataify the uniformity of protein load and transfer efficiency
across the test samples. Membranes failing the test were Compared to the control group, the lead-exposed rats
discarded and measurements were repeated. exhibited a significant elevation of arterial pressure. Ar-
terial pressure measurements obtained by tail plethys-
Measurement of arterial pressure mography closely approximated values obtained by direct
Arterial pressure was determined by tail plethysmo- measurements via carotid artery catheters. Elevation of
graphy (Harvard Apparatus, Natick, MA, USA) as de- arterial blood pressure in the lead-exposed rats was cou-
scribed in our earlier studies [2]. pled with a significant reduction in urinary NOx excre-
tion. No significant difference was found in either body
Effect of lead on SOD activity weight, serum creatinine or creatinine clearance between
In an attempt to explore possible effects of lead on the lead-exposed and the control groups at any point
SOD enzymatic activity, purified SOD preparations from during the study period. Data are depicted in Table 1.
bovine erythrocytes (Sigma) were assayed in the pres-
Effect of tempol infusionence of different concentrations (0, 0.1, 0.25, 2.5, and
25 mol/L) of sodium acetate or lead acetate at room Intravenous infusion of tempol in rats with lead-
temperature. induced HTN resulted in a significant decline in arterial
In another series of experiments, purified SOD prepa- pressure to the values that were comparable to those
rations, as well as rat liver cytosols were incubated in seen in the normal control group. The effect of tempol on
the presence of 0, 0.1, 0.25, 2.5 and 25 mol/L sodium arterial pressure persisted during the 30-minute period
acetate or lead acetate for 20 hours at room temperature following cessation of tempol infusion. In contrast, tem-
and SOD activity was then determined by using a kit pol infusion did not significantly alter arterial pressure
purchased from R & D Systems (Portland, OR, USA). in the control animals. The decline in arterial pressure
during tempol infusion was coupled with a significant
Measurement of total nitrate and nitrite (NOx) rise in urinary NOx in rats with lead-induced HTN. As
The concentration of NOx in the test samples was with arterial pressure, the effect of tempol on urinary
determined by means of the Sievers Instruments Model NOx excretion persisted during the 30-minute recovery
270B Nitric Oxide Analyzer (NOA; Sievers Instru- period after cessation of tempol infusion in the lead-
ments, Boulder, CO, USA) as described earlier [14]. exposed animals. In contrast, tempol infusion had no
effect on urinary NOx excretion in the control group
Data analysis (data are shown in Figs. 1 and 2).
Data are expressed as mean  SEM. Analysis of vari-
Tissue SOD isoformsance (ANOVA), multiple range test and the Student t test
were used as appropriate. P values less than 0.05 were Data are depicted in Figures 3 to 5. The lead exposed
animals exhibited a significant increase in immunodetect-considered significant.
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Fig. 2. Urinary excretion of nitric oxide metabolites (NOx) obtained
at baseline (), during tempol infusion ( ), and recovery periods (30
minutes each; ) in rats with lead-induced hypertension (lead) and
control animals. N  6 animals in each group, Data are shown as x 
SEM. *P  0.01 (ANOVA).
able Cu, Zn SOD abundance in the kidney and brain
tissues as compared with the corresponding values found
in the control group. However, left ventricular Cu, Zn
SOD abundance was similar in the two groups. Although
the mean Mn SOD abundance in the left ventricle and
brain tissues was higher in the lead-exposed animals, the
difference did not reach statistical significance.
Effect of lead on SOD activity in vitro
No significant difference was found in the SOD activity
when purified SOD preparations were assayed in the
presence of 0, 0.1, 0.25, 2.5 and 25mol/L sodium acetate
(placebo) or lead acetate (Fig. 6A).
In another series of experiments, purified SOD prepa-
rations (Fig. 6B) as well as the rat liver cytosols (Fig.
6C) were incubated in the presence of 0, 0.1, 0.25, 2.5
and 25 mol/L sodium acetate (placebo) or lead acetate
for 20 hours at room temperature. Once again, extended
exposure to lead acetate had no effect on the SOD en-
zyme activity of the given preparations when compared
to the sodium acetate or untreated group.
Tissue catalase and glutathione peroxidase data
Results are illustrated in Figures 3 to 5. No significant Fig. 3. Representative Western blot and group data for (A ) Cu, Zn
difference was found in either catalase or glutathione SOD, (B ) catalase and (C ) glutathione peroxidase protein abundance
in the kidney of lead-treated and control rats. Values are presented asperoxidase abundance in any of the tissues tested.
mean relative optical density  SD. *P  0.05.
Tissue gp91 phox data
Data are shown in Figure 7. gp91 phox protein abun-
dance was significantly higher in the brain and insignifi- tenance of various forms of genetic and acquired HTN.
cantly higher in the renal cortex and heart of the lead- First, increased ROS activity has been found in animals
treated group as compared with the control group.
and humans with various forms of HTN. These include
rats with lead-induced HTN [1–4, 10, 11], chronic renal
DISCUSSION failure [15, 16], cyclosporine-induced HTN [17, 18], spon-
taneously hypertensive rats [19–23], salt-sensitive DahlCompelling evidence has recently emerged implicating
the role of oxidative stress in the pathogenesis and main- rats, [24, 25], rats fed a high-fat, high-sugar diet [26, 27],
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Fig. 4. Representative Western blot and group data for (A ) Cu, Zn SOD, (B ) Mn SOD, (C ) catalase and (D ) glutathione peroxidase protein
abundance in the brain of lead-treated and control rats. Values are presented as mean relative optical density  SD. *P  0.05.
and women with pre-eclampsia [28]. Second, alleviation a rise in urinary NOx excretion pointing to improved NO
availability, which could account, at least in part, forof oxidative stress with a variety of antioxidant regimens
has been shown to ameliorate HTN in several different the fall in blood pressure in lead-exposed animals. In
contrast to the lead-exposed animals that showed a dra-forms of HTN [1–4, 15, 21–25], thus enforcing the notion
that oxidative stress contributes to the maintenance of matic fall in arterial pressure and a rise in urinary NOx
excretion, normal control animals exhibited no discern-HTN. Finally, we recently showed that induction of oxi-
dative stress by glutathione depletion causes severe sus- ible response to tempol administration. This observation
argues against a nonspecific effect of tempol on eithertained HTN in genetically normal, otherwise intact ani-
mals, thus, providing convincing evidence that oxidative arterial pressure or urinary NOx excretion and points to
increased abundance of superoxide in rats with lead-stress, per se, can cause HTN [29].
In a series of earlier studies, we have shown that lead- induced HTN.
While the presence of oxidative stress in lead-inducedinduced HTN is associated with and is due, at least in
part, to increased ROS activity [1–4, 10, 11]. The studies HTN is well established, its underlying mechanism is
unknown. Oxidative stress can occur as a result of eitherfurther showed evidence for increased superoxide [5, 12]
and hydroxyl radical production in lead-exposed rats and increased ROS generation, depressed antioxidant system
or both. The natural antioxidant system consists of acultured endothelial cells [10, 11].
Intravenous infusion of tempol, which has been shown series of antioxidant enzymes and numerous endogenous
and dietary antioxidant compounds that react with andto trap superoxide [30, 31], resulted in normalization of
arterial pressure in rats with lead-induced HTN em- inactivate ROS. The primary ROS produced in the aero-
bic organisms is superoxide that is a highly reactive andployed in the present study. This was accompanied by
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Fig. 5. Representative Western blot and group data for (A ) Cu, Zn SOD, (B ) Mn SOD, (C ) catalase and (D ) glutathione peroxidase protein
abundance in the heart of lead-treated and control (CTL) rats. Values are presented as mean relative optical density  SD.
cytotoxic agent. Superoxide is converted to H2O2 by a nificant change in the enzymatic activity of SOD after
incubation with different concentrations of lead acetate.group of enzymes known as SOD. H2O2, in turn, is con-
verted to water and molecular oxygen by either CAT or Catalase is a tetrameric peroxidase enzyme which con-
verts H2O2 to water and molecular oxygen and whose geneGPX. In addition, GPX can reduce lipid peroxides and
other organic hydroperoxides that are highly cytotoxic expression is regulated by H2O2 [32]. CAT plays an im-
portant role in ROS metabolism and in adaptation to oxi-products. Accordingly, SOD, CAT and GPX constitute
the principal components of the antioxidant defense sys- dant stress [32]. Immunodetectable CAT abundance in the
kidney, brain and left ventricle of rats with lead-inducedtem and their deficiencies can cause oxidative stress. The
present study, therefore, was conducted to determine HTN was similar to that found in the control animals.
Thus, chronic exposure to low levels of lead does notthe effect of chronic exposure to low levels of lead that
causes longstanding HTN and oxidative stress on the appear to affect tissue CAT abundance in this model.
Glutathione peroxidase is a selenium-containing tetra-abundance of these enzymes. The study revealed a mild
but significant increase in immunodetectable Cu, Zn SOD meric enzyme that reduces H2O2, lipoperoxides and or-
ganic hydroperoxides using glutathione as a hydrogenabundance in the kidney and brain of rats with lead-
induced HTN. However, immunodetectable Mn SOD donor. Gene expression of GPX is up-regulated by H2O2
and other ROS [32]. As with CAT, tissue abundance ofabundance was not significantly altered in the lead-ex-
posed animals. These findings clearly exclude a quantita- GPX was not altered in rats with lead-induced HTN.
Based on our findings, oxidative stress in lead-inducedtive deficiency of intracellular SOD isoforms in this
model. Moreover, in vitro experiments revealed no sig- HTN does not appear to be due to a primary down regula-
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Fig. 7. Representative Western blots and group data depicting
gp91phox protein abundance in the (A ) brain, (B ) renal cortex and (C )
heart of lead-exposed and control rats. N 6 in each group, *P  0.05.
Fig. 6. Purified Cu, Zn SOD preparations from bovine erythrocytes acetate (placebo) or lead acetate for 20 hours at room temperature and
(Sigma) were assayed in the presence of various concentrations of sodium the enzyme activity was then measured by using a kit purchased from
acetate (placebo;) or lead acetate (; A ). In another series of experi- R&D Systems. One SOD unit is defined as the activity that doubles the
ments, purified Cu, Zn SOD preparations (B) or control rat liver cytosols auto-oxidation rate of the control blank (Vs/Vc  2) as described in the
(C) were incubated in the presence of various concentrations of sodium manufacturer’s directions. The x-axis is presented on a logarithmic scale.
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blood lead concentration in bus drivers. Environ Health Perspecttion of either SOD isoforms, CAT or GPX. In fact, Cu,
78:131–137, 1988
Zn SOD was mildly elevated and Mn SOD, CAT and 7. Harlan WR: The relationship of blood lead levels to blood pres-
GPX were normal in this model. The reason for the sure in the U.S. population. Environ Health Perspect 78:9–13, 1988
8. Khalil-Manesh F, Gonick HC, Weiler EW, et al: Effect of chela-observed increase in the Cu, Zn SOD abundance in rats
tion treatment with dimercaptosuccinic acid (DMSA) on lead-with lead-induced HTN is not clear. However, it may related blood pressure changes. Environs Res 65:86–99, 1994
represent a compensatory response to oxidative stress 9. Ding Y, Gonick HC, Vaziri ND: Lead promotes hydroxyl radical
generation and lipid peroxidation in cultured aortic endothelialthat is known to augment SOD expression [32]. Since
cells. Am J Hypertens 13:552–555, 2000the antioxidant enzymes are regulated by ROS, the lack 10. Ding Y, Gonick HC, Vaziri ND, et al: Lead-induced hypertension:
of up-regulation of CAT and GPX despite the presence Increased hydroxyl radical production. Am J Hypertens 14:169–173,
2001of oxidative stress may represent an inappropriate re-
11. Ding Y, Vaziri ND, Gonick HC: Lead-induced hypertension. II.sponse. In view of the absence of a detectable primary Response to sequential infusions of L-arginine, superoxide dismu-
deficiency of the main antioxidant enzymes in the lead tase, and nitroprusside. Environ Res 76:107–113, 1998
12. Vaziri ND, Ding Y: Effect of lead on NO synthase expressiontreated animals, we sought to explore expression of the
in coronary endothelial cells: Role of superoxide. Hypertensionmain ROS generating enzyme, namely NAD(P)H oxide,
37:223–226, 2001
in this model. This enzyme has been recently recognized 13. Vaziri ND, Ni Z, Zhang YP, et al: Depressed renal and vascular
nitric oxide synthase expression in cyclosporine-induced hyperten-as an important source of superoxide in cardiovascular
sion. Kidney Int 54:482–491, 1998tissues [33, 34]. Moreover, increased NAD(P)H oxidase-
14. Vaziri ND, Ni Z, Oveisi F: Upregulation of renal and vascular
derived superoxide has been implicated in the pathogen- nitric oxide synthase in young spontaneously hypertensive rats.
Hypertension 31:1248–1254, 1998esis of angiotensin II-induced hypertension [33]. Our rats
15. Vaziri ND, Oveisi F, Ding Y: Role of increased oxygen freewith lead-induced hypertension exhibited a significant
radical activity in the pathogenesis of uremic hypertension. Kidney
increase in the immunodetectable gp91 phox subunit of Int 53:1748–1754, 1998
NAD(P)H oxidase in the brain and insignificantly higher 16. Vaziri ND, Ni Z, Oveisi F, et al: Enhanced nitric oxide inactivation
and protein nitration by reactive oxygen species in renal insuffi-levels in the heart and renal cortex. These observations
ciency. Hypertension 39:135–141, 2002suggest that increased superoxide activity in the lead ex- 17. Navarro-Antolı´n J, Herna´ndez-Perera O, Lo´pez-Ongil S, et
posed animals, in part, may be mediated by up-regulation al: CsA and FK506 up-regulate eNOS expression: Role of reactive
oxygen species and AP-1. Kidney Int 54(Suppl 68):S20–S24, 1998of NAD(P)H oxidase. More comprehensive studies are
18. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, etplanned to explore this possibility.
al: Role of reactive oxygen species in the signaling cascade of
In conclusion, rats with lead-induced HTN exhibit oxi- cyclosporine A-mediated up-regulation of eNOS in vascular endo-
thelial cells. Br J Pharmacol 124:447–454, 1998dative stress that is associated with mild up-regulation
19. Tschudi MR, Mesaros S, Luscher TF, et al: Direct in situ measure-of superoxide generating enzymes, NAD(P)H oxidase
ment of nitric oxide in mesenteric resistance arteries. Increased
with no evidence of quantitative SOD, CAT or GPX decomposition by superoxide in hypertension. Hypertension 27:32–
35, 1996deficiencies.
20. Cosentino F, Patton S, D’Uscio LV, et al: Tetrahydrobiopterin
alters superoxide and nitric oxide release in prehypertensive rats.ACKNOWLEDGMENT J Clin Invest 101:1530–1537, 1998
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